| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |